These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
(Mark
One)
|
|
x
|
QUARTERLY
REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF
1934
|
o
|
TRANSITION
REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF
1934
|
Delaware
|
75-1618004
|
(State
or other jurisdiction of
|
(IRS
Employer
|
incorporation
or organization)
|
Identification
No.)
|
8000
S. Federal Way, Boise, Idaho
|
83716-9632
|
(Address
of principal executive offices)
|
(Zip
Code)
|
Registrant’s
telephone number, including area code
|
(208)
368-4000
|
Large
Accelerated Filer
x
|
Accelerated
Filer
o
|
Non-Accelerated
Filer
o
(Do
not check if a smaller reporting company)
|
Smaller
Reporting Company
o
|
Quarter
ended
|
December
3,
2009
|
December
4,
2008
|
||||||
Net
sales
|
$ | 1,740 | $ | 1,402 | ||||
Cost
of goods sold
|
1,297 | 1,851 | ||||||
Gross margin
|
443 | (449 | ) | |||||
Selling,
general and administrative
|
97 | 102 | ||||||
Research
and development
|
137 | 178 | ||||||
Restructure
|
(1 | ) | (66 | ) | ||||
Other
operating (income) expense, net
|
9 | 9 | ||||||
Operating income
(loss)
|
201 | (672 | ) | |||||
Interest
income
|
2 | 10 | ||||||
Interest
expense
|
(47 | ) | (41 | ) | ||||
Other
non-operating income (expense), net
|
56 | (10 | ) | |||||
212 | (713 | ) | ||||||
Income
tax (provision) benefit
|
7 | (13 | ) | |||||
Equity
in net losses of equity method investees, net of tax
|
(17 | ) | (5 | ) | ||||
Net income
(loss)
|
202 | (731 | ) | |||||
Net
loss attributable to noncontrolling interests
|
2 | 13 | ||||||
Net income (loss) attributable
to Micron
|
$ | 204 | $ | (718 | ) | |||
Earnings
(loss) per share:
|
||||||||
Basic
|
$ | 0.24 | $ | (0.93 | ) | |||
Diluted
|
0.23 | (0.93 | ) | |||||
Number
of shares used in per share calculations:
|
||||||||
Basic
|
846.3 | 773.3 | ||||||
Diluted
|
1,000.7 | 773.3 | ||||||
As
of
|
December
3,
2009
|
September
3,
2009
|
||||||
Assets
|
||||||||
Cash
and equivalents
|
$ | 1,565 | $ | 1,485 | ||||
Receivables
|
1,091 | 798 | ||||||
Inventories
|
1,037 | 987 | ||||||
Other
current assets
|
76 | 74 | ||||||
Total current
assets
|
3,769 | 3,344 | ||||||
Intangible
assets, net
|
334 | 344 | ||||||
Property,
plant and equipment, net
|
6,876 | 7,089 | ||||||
Equity
method investments
|
366 | 315 | ||||||
Other
assets
|
381 | 367 | ||||||
Total assets
|
$ | 11,726 | $ | 11,459 | ||||
Liabilities
and equity
|
||||||||
Accounts
payable and accrued expenses
|
$ | 1,059 | $ | 1,037 | ||||
Deferred
income
|
212 | 209 | ||||||
Equipment
purchase contracts
|
353 | 222 | ||||||
Current
portion of long-term debt
|
618 | 424 | ||||||
Total current
liabilities
|
2,242 | 1,892 | ||||||
Long-term
debt
|
2,143 | 2,379 | ||||||
Other
liabilities
|
250 | 249 | ||||||
Total
liabilities
|
4,635 | 4,520 | ||||||
Commitments
and contingencies
|
||||||||
Micron
shareholders’ equity:
|
||||||||
Common stock, $0.10 par value,
authorized 3,000 shares, issued and outstanding 849.8 million and 848.7
million shares, respectively
|
85 | 85 | ||||||
Additional
capital
|
7,287 | 7,257 | ||||||
Accumulated
deficit
|
(2,181 | ) | (2,385 | ) | ||||
Accumulated other comprehensive
income (loss)
|
4 | (4 | ) | |||||
Total Micron shareholders’
equity
|
5,195 | 4,953 | ||||||
Noncontrolling
interests in subsidiaries
|
1,896 | 1,986 | ||||||
Total equity
|
7,091 | 6,939 | ||||||
Total liabilities and
equity
|
$ | 11,726 | $ | 11,459 |
Quarter
ended
|
December
3,
2009
|
December
4,
2008
|
||||||
Cash
flows from operating activities
|
||||||||
Net
income (loss)
|
$ | 202 | $ | (731 | ) | |||
Adjustments
to reconcile net income (loss) to net cash provided by operating
activities:
|
||||||||
Depreciation and
amortization
|
491 | 605 | ||||||
Share-based
compensation
|
31 | 9 | ||||||
Equity in net losses of equity
method investees, net of tax
|
17 | 5 | ||||||
Provision to write down
inventories to estimated market values
|
9 | 369 | ||||||
Gain from Inotera stock
issuance
|
(56 | ) | -- | |||||
Noncash restructure charges
(credits)
|
(6 | ) | (83 | ) | ||||
Change in operating assets and
liabilities:
|
||||||||
(Increase) decrease in
receivables
|
(324 | ) | 138 | |||||
Decrease in customer
prepayments
|
(60 | ) | (29 | ) | ||||
(Increase) decrease in
inventories
|
(59 | ) | 39 | |||||
Increase (decrease) in accounts
payable and accrued expenses
|
66 | (67 | ) | |||||
Increase in deferred
income
|
-- | 78 | ||||||
Other
|
15 | 26 | ||||||
Net cash provided by operating
activities
|
326 | 359 | ||||||
Cash
flows from investing activities
|
||||||||
Expenditures
for property, plant and equipment
|
(62 | ) | (270 | ) | ||||
(Increase)
in restricted cash
|
(30 | ) | -- | |||||
Acquisition
of equity method investment
|
-- | (409 | ) | |||||
Proceeds
from maturities of available-for-sale securities
|
-- | 123 | ||||||
Proceeds
from sales of property, plant and equipment
|
31 | 6 | ||||||
Other
|
36 | 61 | ||||||
Net cash used for investing
activities
|
(25 | ) | (489 | ) | ||||
Cash
flows from financing activities
|
||||||||
Repayments
of debt
|
(280 | ) | (163 | ) | ||||
Distributions
to noncontrolling interests
|
(88 | ) | (150 | ) | ||||
Payments
on equipment purchase contracts
|
(49 | ) | (64 | ) | ||||
Proceeds
from debt
|
200 | 285 | ||||||
Other
|
(4 | ) | 4 | |||||
Net cash used for financing
activities
|
(221 | ) | (88 | ) | ||||
Net increase (decrease) in cash
and equivalents
|
80 | (218 | ) | |||||
Cash
and equivalents at beginning of period
|
1,485 | 1,243 | ||||||
Cash
and equivalents at end of period
|
$ | 1,565 | $ | 1,025 | ||||
Supplemental
disclosures
|
||||||||
Income
taxes paid, net
|
$ | (2 | ) | $ | (8 | ) | ||
Interest
paid, net of amounts capitalized
|
(36 | ) | (29 | ) | ||||
Noncash
investing and financing activities:
|
||||||||
Equipment acquisitions on
contracts payable and capital leases
|
176 | 153 |
Receivables
|
December
3,
2009
|
September
3,
2009
|
||||||
Trade receivables (net of
allowance for doubtful accounts of $5 million and $5 million,
respectively)
|
$ | 884 | $ | 591 | ||||
Related party
receivables
|
53 | 70 | ||||||
Income and other
taxes
|
62 | 49 | ||||||
Other
|
92 | 88 | ||||||
$ | 1,091 | $ | 798 |
Inventories
|
December
3,
2009
|
September
3,
2009
|
||||||
Finished goods
|
$ | 298 | $ | 233 | ||||
Work in process
|
629 | 649 | ||||||
Raw materials and
supplies
|
110 | 105 | ||||||
$ | 1,037 | $ | 987 |
Intangible
Assets
|
||||||||||||||||
December
3, 2009
|
September
3, 2009
|
|||||||||||||||
Gross
Amount
|
Accumulated
Amortization
|
Gross
Amount
|
Accumulated
Amortization
|
|||||||||||||
Product and process
technology
|
$ | 436 | $ | (183 | ) | $ | 439 | $ | (181 | ) | ||||||
Customer
relationships
|
127 | (54 | ) | 127 | (50 | ) | ||||||||||
Other
|
28 | (20 | ) | 28 | (19 | ) | ||||||||||
$ | 591 | $ | (257 | ) | $ | 594 | $ | (250 | ) |
Property,
Plant and Equipment
|
December
3,
2009
|
September
3,
2009
|
||||||
Land
|
$ | 96 | $ | 96 | ||||
Buildings
|
4,471 | 4,463 | ||||||
Equipment
|
12,189 | 11,843 | ||||||
Construction in
progress
|
49 | 47 | ||||||
Software
|
272 | 269 | ||||||
17,077 | 16,718 | |||||||
Accumulated
depreciation
|
(10,201 | ) | (9,629 | ) | ||||
$ | 6,876 | $ | 7,089 |
Equity
Method Investments
|
Accounts
Payable and Accrued Expenses
|
December
3,
2009
|
September
3,
2009
|
||||||
Accounts
payable
|
$ | 541 | $ | 526 | ||||
Salaries, wages and
benefits
|
172 | 147 | ||||||
Related party
payables
|
129 | 83 | ||||||
Customer
advances
|
90 | 150 | ||||||
Income and other
taxes
|
40 | 32 | ||||||
Other
|
87 | 99 | ||||||
$ | 1,059 | $ | 1,037 |
Debt
|
December
3,
2009
|
September
3,
2009
|
||||||
Convertible senior notes,
stated interest rate of 1.875%, effective interest rate of 7.9%, net of
discount of $282 million and $295 million, respectively, due June
2014
|
$ | 1,018 | $ | 1,005 | ||||
TECH credit facility, effective
interest rates of 3.9% and 3.6% , respectively, net of discount of $3
million and $2 million, respectively, due in periodic installments through
May 2012
|
497 | 548 | ||||||
Capital lease obligations,
weighted-average imputed interest rate of 6.7%, due in monthly
installments through February 2023
|
543 | 559 | ||||||
Convertible senior notes,
interest rate of 4.25%, due October 2013
|
230 | 230 | ||||||
EDB notes, denominated in
Singapore dollars, interest rate of 5.4%, due February
2012
|
217 | 208 | ||||||
Mai-Liao Power note, effective
imputed interest rate of 12.1%, net of discount of $14 million and $18
million, respectively, due November 2010
|
186 | 182 | ||||||
Convertible subordinated notes,
interest rate of 5.6%, due April 2010
|
70 | 70 | ||||||
Other notes
|
-- | 1 | ||||||
2,761 | 2,803 | |||||||
Less current
portion
|
(618 | ) | (424 | ) | ||||
$ | 2,143 | $ | 2,379 |
As of
|
December
3,
2009
|
September
3,
2009
|
||||||
Carrying amount of the equity
component
|
$ | 394 | $ | 394 | ||||
Principal amount of the
Convertible Notes
|
1,300 | 1,300 | ||||||
Unamortized
discount
|
282 | 295 | ||||||
Net carrying amount of the
Convertible Notes
|
1,018 | 1,005 |
Quarter
Ended
|
||||||||
December
3,
2009
|
December
4,
2008
|
|||||||
Effective interest
rate
|
7.9 | % | 7.9 | % | ||||
Interest costs related to
contractual interest coupon
|
6 | 7 | ||||||
Interest costs related to
amortization of discount and issuance costs
|
13 | 13 |
Consolidated
Statement of Operations
|
||||||||||||||||
As
Previously Reported
|
Effect
of Adoption
|
As
Retrospectively Adjusted
|
||||||||||||||
Noncontrolling
Interests
|
Convertible
Debt
|
|||||||||||||||
Year
ended September 3, 2009:
|
||||||||||||||||
Cost
of goods sold
|
$ | 5,242 | $ | -- | $ | 1 | $ | 5,243 | ||||||||
Interest
expense
|
(135 | ) | -- | (47 | ) | (182 | ) | |||||||||
Income
tax (provision)
|
(2 | ) | -- | 1 | (1 | ) | ||||||||||
Net loss
|
(1,835 | ) | (111 | ) | (47 | ) | (1,993 | ) | ||||||||
Net loss attributable to
Micron
|
-- | (1,835 | ) | (47 | ) | (1,882 | ) | |||||||||
Net
loss per share:
|
||||||||||||||||
Basic and
diluted
|
(2.29 | ) | -- | (0.06 | ) | (2.35 | ) | |||||||||
Year
ended August 28, 2008:
|
||||||||||||||||
Interest
expense
|
$ | (82 | ) | $ | -- | $ | (36 | ) | $ | (118 | ) | |||||
Net loss
|
(1,619 | ) | (10 | ) | (36 | ) | (1,665 | ) | ||||||||
Net loss attributable to
Micron
|
-- | (1,619 | ) | (36 | ) | (1,655 | ) | |||||||||
Net
loss per share:
|
||||||||||||||||
Basic and
diluted
|
(2.10 | ) | -- | (0.04 | ) | (2.14 | ) | |||||||||
Quarter
ended December 4, 2008:
|
||||||||||||||||
Interest
expense
|
$ | (30 | ) | $ | -- | $ | (11 | ) | $ | (41 | ) | |||||
Other
non-operating income (expense), net
|
(9 | ) | -- | (1 | ) | (10 | ) | |||||||||
Net loss
|
(706 | ) | (13 | ) | (12 | ) | (731 | ) | ||||||||
Net loss attributable to
Micron
|
-- | (706 | ) | (12 | ) | (718 | ) | |||||||||
Net
loss per share:
|
||||||||||||||||
Basic and
diluted
|
(0.91 | ) | -- | (0.02 | ) | (0.93 | ) |
Consolidated
Balance Sheet
|
||||||||||||||||
As
Previously Reported
|
Effect
of Adoption
|
As
Retrospectively Adjusted
|
||||||||||||||
As
of September 3, 2009
|
Noncontrolling
Interests
|
Convertible
Debt
|
||||||||||||||
Assets
|
||||||||||||||||
Property,
plant and equipment, net
|
$ | 7,081 | $ | -- | $ | 8 | $ | 7,089 | ||||||||
Other
assets
|
371 | -- | (4 | ) | 367 | |||||||||||
Total assets
|
11,455 | -- | 4 | 11,459 | ||||||||||||
Liabilities
and equity
|
||||||||||||||||
Long-term
debt
|
$ | 2,674 | $ | -- | $ | (295 | ) | $ | 2,379 | |||||||
Total
liabilities
|
4,815 | -- | (295 | ) | 4,520 | |||||||||||
Micron
shareholders’ equity
|
||||||||||||||||
Additional
capital
|
6,863 | -- | 394 | 7,257 | ||||||||||||
Accumulated
deficit
|
(2,291 | ) | -- | (94 | ) | (2,385 | ) | |||||||||
Accumulated other comprehensive
(loss)
|
(3 | ) | -- | (1 | ) | (4 | ) | |||||||||
Total equity of Micron
shareholders
|
-- | 4,654 | 299 | 4,953 | ||||||||||||
Total equity
|
4,654 | 1,986 | 299 | 6,939 | ||||||||||||
Total liabilities and
equity
|
11,455 | -- | 4 | 11,459 |
Consolidated
Statement of Cash Flows
|
||||||||||||||||
As
Previously Reported
|
Effect
of Adoption
|
As
Retrospectively Adjusted
|
||||||||||||||
Noncontrolling
Interests
|
Convertible
Debt
|
|||||||||||||||
Year
ended September 3, 2009:
|
||||||||||||||||
Cash flows from operating
activities
|
||||||||||||||||
Net
loss
|
$ | (1,835 | ) | $ | (111 | ) | $ | (47 | ) | $ | (1,993 | ) | ||||
Depreciation
and amortization
|
2,139 | -- | 47 | 2,186 | ||||||||||||
Noncontrolling
interests in net income (loss)
|
(111 | ) | 111 | -- | -- | |||||||||||
Year
ended August 28, 2008:
|
||||||||||||||||
Cash flows from operating
activities
|
||||||||||||||||
Net
loss
|
$ | (1,619 | ) | $ | (10 | ) | $ | (36 | ) | $ | (1,665 | ) | ||||
Depreciation
and amortization
|
2,060 | -- | 36 | 2,096 | ||||||||||||
Noncontrolling
interests in net income (loss)
|
(10 | ) | 10 | -- | -- | |||||||||||
Quarter
ended December 4, 2008:
|
||||||||||||||||
Cash flows from operating
activities
|
||||||||||||||||
Net
loss
|
$ | (706 | ) | $ | (13 | ) | $ | (12 | ) | $ | (731 | ) | ||||
Depreciation
and amortization
|
594 | -- | 11 | 605 | ||||||||||||
Other
(reflects current period classification)
|
12 | 13 | 1 | 26 |
Currency
|
Notional
Amount Outstanding
(in
U.S. Dollars)
|
Balance
Sheet Location
|
Fair
Value
of
Asset (Liability)
|
||||||
Singapore
dollar
|
$ | 297 |
Receivables
|
$ | 0 | ||||
Euro
|
216 |
Accounts
payable and accrued expenses
|
(0 | ) | |||||
Yen
|
85 |
Accounts
payable and accrued expenses
|
(1 | ) | |||||
$ | 598 | $ | (1 | ) |
As
of December 3, 2009
|
As
of September 3, 2009
|
|||||||||||||||||||||||||||||||
Level
1
|
Level
2
|
Level
3
|
Total
|
Level
1
|
Level
2
|
Level
3
|
Total
|
|||||||||||||||||||||||||
Money
market
(1)
|
$ | 1,388 | $ | -- | $ | -- | $ | 1,388 | $ | 1,184 | $ | -- | $ | -- | $ | 1,184 | ||||||||||||||||
Certificates
of deposit
(2)
|
-- | 173 | -- | 173 | -- | 217 | -- | 217 | ||||||||||||||||||||||||
Marketable
equity investments
(3)
|
16 | -- | -- | 16 | 15 | -- | -- | 15 | ||||||||||||||||||||||||
Fixed
assets held for sale
(3)(4)
|
-- | -- | 68 | 68 | -- | -- | -- | -- | ||||||||||||||||||||||||
$ | 1,404 | $ | 173 | $ | 68 | $ | 1,645 | $ | 1,199 | $ | 217 | $ | -- | $ | 1,416 | |||||||||||||||||
(1)
Included in cash
and
equivalents
|
||||||||||||||||||||||||||||||||
(2)
$113 million and $60 million
included in cash
and equivalents and other
noncurrent assets, respectively, as of December 3, 2009 and $187 million
and $30 million, respectively, as of September 3,
2009
|
||||||||||||||||||||||||||||||||
(3)
Included in other noncurrent
assets
|
||||||||||||||||||||||||||||||||
(4)
The Company adopted the
accounting standard for fair value measurements of nonfinancial assets and
nonfinancial liabilities at the beginning of 2010.
|
Quarter
ended
|
||||||||
December
3,
2009
|
December
4,
2008
|
|||||||
Average expected life in
years
|
5.10 | 4.75 | ||||||
Weighted-average expected
volatility
|
61 | % | 60 | % | ||||
Weighted-average risk-free
interest rate
|
2.3 | % | 2.6 | % |
Quarter
ended
|
||||||||
December
3,
2009
|
December
4,
2008
|
|||||||
Stock-based
compensation expense by caption:
|
||||||||
Cost of goods
sold
|
$ | 7 | $ | 4 | ||||
Selling, general and
administrative
|
19 | 2 | ||||||
Research and
development
|
5 | 3 | ||||||
$ | 31 | $ | 9 | |||||
Stock-based
compensation expense by type of award:
|
||||||||
Stock options
|
$ | 8 | $ | 7 | ||||
Restricted
stock
|
23 | 2 | ||||||
$ | 31 | $ | 9 |
Quarter
Ended
|
||||||||
December
3,
2009
|
December
4,
2008
|
|||||||
(Gain)
write-down of equipment
|
$ | (4 | ) | $ | 56 | |||
Severance
and other termination benefits
|
1 | 22 | ||||||
Gain
from termination of NAND Flash supply agreement
|
-- | (144 | ) | |||||
Other
|
2 | -- | ||||||
$ | (1 | ) | $ | (66 | ) |
Quarter
Ended
|
||||||||
December
3,
2009
|
December
4,
2008
|
|||||||
Losses
from changes in currency exchange rates
|
$ | 21 | $ | 3 | ||||
(Gain)
loss on disposals of property, plant and equipment
|
(2 | ) | 14 | |||||
Other
|
(10 | ) | (8 | ) | ||||
$ | 9 | $ | 9 |
Quarter
ended
|
||||||||
December
3,
2009
|
December
4,
2008
|
|||||||
Net income (loss) available to
Micron’s shareholders - Basic
|
$ | 204 | $ | (718 | ) | |||
Net effect of assumed
conversion of debt
|
23 | -- | ||||||
Net income (loss) available to
Micron’s shareholders - Diluted
|
$ | 227 | $ | (718 | ) | |||
Weighted-average common shares
outstanding - Basic
|
846.3 | 773.3 | ||||||
Net effect of dilutive stock
options and assumed conversion of debt
|
154.4 | -- | ||||||
Weighted-average common shares
outstanding - Diluted
|
1,000.7 | 773.3 | ||||||
Earnings (loss) per
share:
|
||||||||
Basic
|
$ | 0.24 | $ | (0.93 | ) | |||
Diluted
|
0.23 | (0.93 | ) |
As
of
|
December
3,
2009
|
September
3,
2009
|
||||||
Assets
|
||||||||
Cash
and equivalents
|
$ | 88 | $ | 114 | ||||
Receivables
|
141 | 111 | ||||||
Inventories
|
148 | 161 | ||||||
Other
current assets
|
6 | 8 | ||||||
Total current
assets
|
383 | 394 | ||||||
Property,
plant and equipment, net
|
3,201 | 3,377 | ||||||
Other
assets
|
58 | 63 | ||||||
Total assets
|
$ | 3,642 | $ | 3,834 | ||||
Liabilities
|
||||||||
Accounts
payable and accrued expenses
|
$ | 75 | $ | 93 | ||||
Deferred
income
|
136 | 137 | ||||||
Equipment
purchase contracts
|
2 | 1 | ||||||
Current
portion of long-term debt
|
6 | 6 | ||||||
Total current
liabilities
|
219 | 237 | ||||||
Long-term
debt
|
66 | 66 | ||||||
Other
liabilities
|
3 | 4 | ||||||
Total
liabilities
|
$ | 288 | $ | 307 | ||||
Amounts exclude intercompany
balances that are eliminated in the Company’s consolidated balance sheets.
IMFT and IMFS are
aggregated as IM Flash in this disclosure due to the similarity of their
ownership structure, function, operations and the way the Company’s
management reviews the results of their operations.
|
As
of
|
December
3,
2009
|
September
3,
2009
|
||||||
Current
assets
|
$ | 27 | $ | 25 | ||||
Noncurrent
assets (primarily property, plant and equipment)
|
90 | 97 | ||||||
Current
liabilities
|
5 | 8 | ||||||
Amounts
exclude intercompany balances that are eliminated in the Company’s
consolidated balance sheets.
|
Quarter
ended
|
||||||||
December
3,
2009
|
December
4,
2008
|
|||||||
Net sales:
|
||||||||
Memory
|
$ | 1,623 | $ | 1,222 | ||||
All Other
|
117 | 180 | ||||||
Total consolidated net
sales
|
$ | 1,740 | $ | 1,402 | ||||
Operating income
(loss):
|
||||||||
Memory
|
$ | 213 | $ | (675 | ) | |||
All Other
|
(12 | ) | 3 | |||||
Total consolidated operating
income (loss)
|
$ | 201 | $ | (672 | ) |
First
Quarter
|
Fourth
Quarter
|
||||||||||||||||||||||||||
2010
|
%
of net sales
|
2009
|
%
of net sales
|
2009
|
%
of net sales
|
||||||||||||||||||||||
Net
sales:
|
|||||||||||||||||||||||||||
Memory
|
$ | 1,623 | 93 | % | $ | 1,222 | 87 | % | $ | 1,179 | 91 | % | |||||||||||||||
All Other
|
117 | 7 | % | 180 | 13 | % | 123 | 9 | % | ||||||||||||||||||
$ | 1,740 | 100 | % | $ | 1,402 | 100 | % | $ | 1,302 | 100 | % | ||||||||||||||||
Gross
margin:
|
|||||||||||||||||||||||||||
Memory
|
$ | 442 | 27 | % | $ | (502 | ) | (41 | ) | % | $ | 145 | 12 | % | |||||||||||||
All Other
|
1 | 1 | % | 53 | 29 | % | 24 | 20 | % | ||||||||||||||||||
$ | 443 | 25 | % | $ | (449 | ) | (32 | ) | % | $ | 169 | 13 | % | ||||||||||||||
Selling,
general and administrative
|
$ | 97 | 6 | % | $ | 102 | 7 | % | $ | 82 | 6 | % | |||||||||||||||
Research
and development
|
137 | 8 | % | 178 | 13 | % | 139 | 11 | % | ||||||||||||||||||
Restructure
|
(1 | ) | (0 | ) | % | (66 | ) | (5 | ) | % | 12 | 1 | % | ||||||||||||||
Other
operating (income) expense, net
|
9 | 1 | % | 9 | 1 | % | (15 | ) | (1 | ) | % | ||||||||||||||||
Equity
in net losses of equity method investees
|
(17 | ) | (1 | ) | % | (5 | ) | (0 | ) | % | (34 | ) | (3 | ) | % | ||||||||||||
Net
income (loss) attributable to Micron
|
204 | 12 | % | (718 | ) | (51 | ) | % | (100 | ) | (8 | ) | % |
First
Quarter
|
Fourth
Quarter
|
|||||||||||
2010
|
2009
|
2009
|
||||||||||
(amounts
in millions)
|
||||||||||||
Inventory
write-downs
|
$ | -- | $ | (369 | ) | $ | -- | |||||
Estimated
effect of previous inventory write-downs
|
22 | 157 | 91 | |||||||||
Net effect of inventory
write-downs
|
$ | 22 | $ | (212 | ) | $ | 91 |
First
Quarter
|
Fourth
Quarter
|
|||||||||||
2010
|
2009
|
2009
|
||||||||||
Losses
from changes in currency exchange rates
|
$ | 21 | $ | 3 | $ | 5 | ||||||
(Gain)
loss on disposals of property, plant and equipment
|
(2 | ) | 14 | (1 | ) | |||||||
Loss
(credit) on Aptina spinoff
|
-- | -- | (12 | ) | ||||||||
Other
|
(10 | ) | (8 | ) | (7 | ) | ||||||
$ | 9 | $ | 9 | $ | (15 | ) |
Total
|
Remainder
of 2010
|
2011
|
2012
|
2013
|
2014
|
2015
and thereafter
|
||||||||||||||||||||||
(amounts
in millions)
|
||||||||||||||||||||||||||||
Notes payable
1
|
$ | 2,718 | $ | 261 | $ | 452 | $ | 412 | $ | 34 | $ | 1,559 | $ | -- | ||||||||||||||
Capital lease obligations
1
|
628 | 151 | 282 | 52 | 21 | 21 | 101 | |||||||||||||||||||||
Operating
leases
|
71 | 14 | 15 | 11 | 11 | 7 | 13 | |||||||||||||||||||||
1
Includes
interest
|
December
3, 2009
|
September
3, 2009
|
|||||||||||||||||||||||
Singapore
Dollars
|
Yen
|
Euro
|
Singapore
Dollars
|
Yen
|
Euro
|
|||||||||||||||||||
(in
millions)
|
||||||||||||||||||||||||
Deferred
tax assets
|
$ | -- | $ | 119 | $ | 4 | $ | -- | $ | 115 | $ | 4 | ||||||||||||
Other
assets
|
25 | 33 | 33 | 25 | 17 | 40 | ||||||||||||||||||
Accounts
payable and accrued expenses
|
(59 | ) | (150 | ) | (176 | ) | (68 | ) | (141 | ) | (99 | ) | ||||||||||||
Debt
|
(299 | ) | (26 | ) | (4 | ) | (289 | ) | (25 | ) | (4 | ) | ||||||||||||
Other
liabilities
|
(10 | ) | (60 | ) | (43 | ) | (8 | ) | (55 | ) | (41 | ) | ||||||||||||
Net assets
(liabilities)
|
$ | (343 | ) | $ | (84 | ) | $ | (186 | ) | $ | (340 | ) | $ | (89 | ) | $ | (100 | ) |
·
|
our
interests could diverge from our partners in the future or we may not be
able to agree with partners on ongoing manufacturing and operational
activities, or on the amount, timing or nature of further investments in
our joint venture;
|
·
|
recognition
of our share of potential Inotera and Aptina losses in our results of
operation;
|
·
|
due
to financial constraints, our partners may be unable to meet their
commitments to us or our joint ventures and may pose credit risks for our
transactions with them;
|
·
|
the
terms of our arrangements may turn out to be
unfavorable;
|
·
|
cash
flows may be inadequate to fund increased capital
requirements;
|
·
|
we
may experience difficulties in transferring technology to joint
ventures;
|
·
|
we
may experience difficulties and delays in ramping production at joint
ventures;
|
·
|
these
operations may be less cost-efficient as a result of underutilized
capacity; and
|
·
|
political
or economic instability may occur in the countries where our joint
ventures and/or partners are
located.
|
·
|
Inotera’s
ability to meet its ongoing
obligations;
|
·
|
costs
associated with manufacturing inefficiencies resulting from underutilized
capacity;
|
·
|
difficulties
in converting Inotera production from Qimonda AG’s (“Qimonda”) trench
technology to our stack technology;
|
·
|
difficulties
in obtaining financing for capital expenditures necessary to convert
Inotera production to our stack
technology;
|
·
|
uncertainties
around the timing and amount of wafer supply we will receive under the
supply agreement;
|
·
|
risks
relating to actions that may be taken or initiated by Qimonda’s bankruptcy
administrator relating to Qimonda’s transfer to the Company of its Inotera
shares and to the possible rejection of or failure to perform under
certain patent and technology license agreements between the Company and
Qimonda;
|
·
|
obligations
during the technology transition period to procure product based on a
competitor’s technology which may be difficult to sell and to provide
support for such product, with respect to which we have limited
technological understanding; and
|
·
|
the
effect on our margins associated with our obligation to purchase product
utilizing Qimonda’s trench technology at a relatively higher cost than
other products manufactured by us and selling them potentially at a lower
price than other products produced by
us.
|
·
|
make
it more difficult for us to make payments on our
debt;
|
·
|
require
us to dedicate a substantial portion of our cash flow from operations and
other capital resources to debt
service;
|
·
|
limit
our future ability to raise funds for capital expenditures, acquisitions,
research and development and other general corporate
requirements;
|
·
|
increase
our vulnerability to adverse economic and semiconductor memory industry
conditions;
|
·
|
expose
us to fluctuations in interest rates with respect to that portion of our
debt which is at a variable rate of interest;
and
|
·
|
require
us to make additional investments in joint ventures to maintain compliance
with financial covenants.
|
·
|
difficulties
in integrating the operations, technologies and products of acquired or
newly formed entities;
|
·
|
increasing
capital expenditures to upgrade and maintain
facilities;
|
·
|
increasing
debt to finance any acquisition or formation of a new
business;
|
·
|
difficulties
in protecting our intellectual property as we enter into a greater number
of licensing arrangements;
|
·
|
diverting
management’s attention from normal daily
operations;
|
·
|
managing
larger or more complex operations and facilities and employees in separate
geographic areas; and
|
·
|
hiring
and retaining key employees.
|
·
|
development
of products that maintain a technological advantage over the products of
our competitors;
|
·
|
accurate
prediction of market requirements and evolving standards, including pixel
resolution, output interface standards, power requirements, optical lens
size, input standards and other
requirements;
|
·
|
timely
completion and introduction of new imaging products that satisfy customer
requirements; and
|
·
|
timely
achievement of design wins with prospective customers, as manufacturers
may be reluctant to change their source of components due to the
significant costs, time, effort and risk associated with qualifying a new
supplier.
|
·
|
we
may be required to replace product or otherwise compensate customers for
costs incurred or damages caused by defective or incompatible product,
and
|
·
|
we
may encounter adverse publicity, which could cause a decrease in sales of
our products.
|
·
|
currency
exchange rate fluctuations;
|
·
|
export
and import duties, changes to import and export regulations, and
restrictions on the transfer of
funds;
|
·
|
political
and economic instability;
|
·
|
problems
with the transportation or delivery of our
products;
|
·
|
issues
arising from cultural or language differences and labor
unrest;
|
·
|
longer
payment cycles and greater difficulty in collecting accounts
receivable;
|
·
|
compliance
with trade, technical standards and other laws in a variety of
jurisdictions;
|
·
|
changes
in economic policies of foreign governments;
and
|
·
|
difficulties
in staffing and managing international
operations.
|
Period
|
(a)
Total number of shares purchased
|
(b)
Average price paid per share
|
(c)
Total number of shares (or units) purchased as part of publicly announced
plans or programs
|
(d)
Maximum number (or approximate dollar value) of shares (or units) that may
yet be purchased under the plans or programs
|
||||||||||||
September
4,
2009 – October
8, 2009
|
252,317 | $ | 7.81 | N/A | N/A | |||||||||||
October
9,
2009 – November
5, 2009
|
34,394 | 8.21 | N/A | N/A | ||||||||||||
November
6,
2009 – December
3, 2009
|
1,989 | 7.48 | N/A | N/A | ||||||||||||
288,700 | 7.86 |
Name
of Nominee
|
Votes
Cast For
|
Votes
Cast Against/Withheld
|
||||||
Teruaki
Aoki
|
655,154,578 | 25,794,325 | ||||||
Steven
R. Appleton
|
647,501,703 | 33,447,200 | ||||||
James
W. Bagley
|
654,901,324 | 26,047,579 | ||||||
Robert
L. Bailey
|
664,090,856 | 16,858,047 | ||||||
Mercedes
Johnson
|
649,349,792 | 31,599,111 | ||||||
Lawrence
N. Mondry
|
654,759,867 | 26,189,036 | ||||||
Robert
E. Switz
|
663,439,456 | 17,509,447 |
Exhibit
|
|||
Number
|
Description
of Exhibit
|
||
3.1
|
Restated
Certificate of Incorporation of the Registrant (1)
|
||
3.2
|
Bylaws
of the Registrant, as amended (2)
|
||
10.84
|
Amendment
Agreement, dated September 25, 2009, to TECH Facility Agreement, dated
March 31, 2008, among TECH Semiconductor Singapore Pte. Ltd. and ABN Amro
Bank N.V., Citibank, N.A., Singapore Branch, Citigroup Global Markets
Singapore Pte Ltd., DBS Bank Ltd and Oversea-Chinese Banking Corporation
Limited, as Original Mandated Lead Arrangers (3)
|
||
10.85
|
Supplemental
Deed, dated September 25, 2009, to Guarantee, dated March 31, 2008, by
Micron Technology, Inc. as Guarantor in favor of ABN Amro Bank N.V.,
Singapore Branch acting as Security Trustee (3)
|
||
10.86
|
Loan
Agreement dated as of November 25, 2009, by and among Micron Semiconductor
B.V., Micron Technology, Inc., and Mai Liao Power Corporation
(4)
|
||
31.1
|
Rule
13a-14(a) Certification of Chief Executive Officer
|
||
31.2
|
Rule
13a-14(a) Certification of Chief Financial Officer
|
||
32.1
|
Certification
of Chief Executive Officer Pursuant to 18 U.S.C. 1350
|
||
32.2
|
Certification
of Chief Financial Officer Pursuant to 18 U.S.C.
1350
|
(1)
|
Incorporated
by reference to Quarterly Report on Form 10-Q for the fiscal quarter ended
May 31, 2001
|
(2)
|
Incorporated
by reference to Current Report on Form 8-K dated December 10,
2009
|
(3)
|
Incorporated
by reference to Current Report on Form 8-K dated September 25,
2009
|
(4)
|
Incorporated
by reference to Current Report on Form 8-K dated November 25,
2009
|
Micron Technology,
Inc.
|
|
(Registrant)
|
|
Date: January
12, 2010
|
/s/ Ronald C.
Foster
|
Ronald
C. Foster
Vice
President of Finance and Chief Financial Officer (Principal Financial and
Accounting Officer)
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
---|
DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
---|
No information found
Customers
Customer name | Ticker |
---|---|
Pitney Bowes Inc. | PBI |
Price
Yield
Owner | Position | Direct Shares | Indirect Shares |
---|